Buy Imatib 400 mg Mesylate is a targeted therapy. Imatinib Mesylate is classified as a signal transduction inhibitor - protein-tyrosine kinase inhibitor. Imatinib mesylate belongs to the signal transduction inhibitor category of targeted therapies. It is particularly a protein-tyrosine kinase inhibitor.